Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 8.39388711 |
2 | epoxygenase P450 pathway (GO:0019373) | 7.78843197 |
3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.47878707 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.39779331 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.39779331 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.06909497 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.06909497 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.76922292 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.26487573 |
10 | tryptophan catabolic process (GO:0006569) | 6.23111062 |
11 | indole-containing compound catabolic process (GO:0042436) | 6.23111062 |
12 | indolalkylamine catabolic process (GO:0046218) | 6.23111062 |
13 | kynurenine metabolic process (GO:0070189) | 6.09199329 |
14 | oxidative demethylation (GO:0070989) | 6.03680370 |
15 | bile acid biosynthetic process (GO:0006699) | 5.95988170 |
16 | tryptophan metabolic process (GO:0006568) | 5.87473015 |
17 | drug metabolic process (GO:0017144) | 5.63623944 |
18 | urea metabolic process (GO:0019627) | 5.60995621 |
19 | urea cycle (GO:0000050) | 5.60995621 |
20 | glyoxylate metabolic process (GO:0046487) | 5.59362249 |
21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58724083 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.46763548 |
23 | protein carboxylation (GO:0018214) | 5.43417744 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.43417744 |
25 | negative regulation of fibrinolysis (GO:0051918) | 5.41220968 |
26 | regulation of protein activation cascade (GO:2000257) | 5.31757073 |
27 | cysteine metabolic process (GO:0006534) | 5.31625382 |
28 | complement activation, alternative pathway (GO:0006957) | 5.31324118 |
29 | regulation of fibrinolysis (GO:0051917) | 5.28326387 |
30 | regulation of plasminogen activation (GO:0010755) | 5.27965645 |
31 | nitrogen cycle metabolic process (GO:0071941) | 5.16618669 |
32 | serine family amino acid catabolic process (GO:0009071) | 5.15876193 |
33 | sulfur amino acid catabolic process (GO:0000098) | 5.13532138 |
34 | bile acid metabolic process (GO:0008206) | 5.07417809 |
35 | regulation of humoral immune response (GO:0002920) | 5.05663861 |
36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04945816 |
37 | phenylpropanoid metabolic process (GO:0009698) | 5.00941176 |
38 | regulation of complement activation (GO:0030449) | 4.96038628 |
39 | aromatic amino acid family metabolic process (GO:0009072) | 4.90812385 |
40 | negative regulation of hemostasis (GO:1900047) | 4.90787415 |
41 | negative regulation of blood coagulation (GO:0030195) | 4.90787415 |
42 | homocysteine metabolic process (GO:0050667) | 4.87521270 |
43 | regulation of triglyceride catabolic process (GO:0010896) | 4.85794769 |
44 | reverse cholesterol transport (GO:0043691) | 4.79009030 |
45 | negative regulation of protein activation cascade (GO:2000258) | 4.76181118 |
46 | lysine catabolic process (GO:0006554) | 4.73936522 |
47 | lysine metabolic process (GO:0006553) | 4.73936522 |
48 | regulation of cholesterol esterification (GO:0010872) | 4.72990249 |
49 | protein-lipid complex remodeling (GO:0034368) | 4.72600928 |
50 | macromolecular complex remodeling (GO:0034367) | 4.72600928 |
51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72600928 |
52 | amino-acid betaine metabolic process (GO:0006577) | 4.71203272 |
53 | tyrosine metabolic process (GO:0006570) | 4.69568017 |
54 | alpha-amino acid catabolic process (GO:1901606) | 4.62846431 |
55 | acute-phase response (GO:0006953) | 4.59254254 |
56 | triglyceride homeostasis (GO:0070328) | 4.56458171 |
57 | acylglycerol homeostasis (GO:0055090) | 4.56458171 |
58 | phospholipid efflux (GO:0033700) | 4.54057310 |
59 | bile acid and bile salt transport (GO:0015721) | 4.48539321 |
60 | imidazole-containing compound metabolic process (GO:0052803) | 4.43932698 |
61 | negative regulation of coagulation (GO:0050819) | 4.43720984 |
62 | indolalkylamine metabolic process (GO:0006586) | 4.43234862 |
63 | glycine metabolic process (GO:0006544) | 4.43091021 |
64 | cellular ketone body metabolic process (GO:0046950) | 4.41177170 |
65 | negative regulation of sterol transport (GO:0032372) | 4.41164116 |
66 | negative regulation of cholesterol transport (GO:0032375) | 4.41164116 |
67 | negative regulation of wound healing (GO:0061045) | 4.38643659 |
68 | cellular biogenic amine catabolic process (GO:0042402) | 4.37615078 |
69 | amine catabolic process (GO:0009310) | 4.37615078 |
70 | coenzyme catabolic process (GO:0009109) | 4.34290370 |
71 | positive regulation of blood coagulation (GO:0030194) | 4.31266205 |
72 | positive regulation of hemostasis (GO:1900048) | 4.31266205 |
73 | plasma lipoprotein particle clearance (GO:0034381) | 4.30994123 |
74 | cellular amino acid catabolic process (GO:0009063) | 4.22148350 |
75 | cellular glucuronidation (GO:0052695) | 4.22049406 |
76 | cholesterol efflux (GO:0033344) | 4.21495846 |
77 | hormone catabolic process (GO:0042447) | 4.15289898 |
78 | alkaloid metabolic process (GO:0009820) | 4.13719711 |
79 | serine family amino acid metabolic process (GO:0009069) | 4.13224882 |
80 | glutamate metabolic process (GO:0006536) | 4.11832778 |
81 | blood coagulation, intrinsic pathway (GO:0007597) | 4.10119326 |
82 | ethanol oxidation (GO:0006069) | 4.06766386 |
83 | ethanol metabolic process (GO:0006067) | 4.06700954 |
84 | plasma lipoprotein particle assembly (GO:0034377) | 4.06649100 |
85 | benzene-containing compound metabolic process (GO:0042537) | 4.05291796 |
86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01727547 |
87 | positive regulation of coagulation (GO:0050820) | 4.00739719 |
88 | negative regulation of complement activation (GO:0045916) | 3.99919872 |
89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95571178 |
90 | cellular modified amino acid catabolic process (GO:0042219) | 3.92616455 |
91 | arginine metabolic process (GO:0006525) | 3.92590010 |
92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.92406193 |
93 | fibrinolysis (GO:0042730) | 3.91511166 |
94 | aldehyde catabolic process (GO:0046185) | 3.88347386 |
95 | cofactor catabolic process (GO:0051187) | 3.84336533 |
96 | S-adenosylmethionine metabolic process (GO:0046500) | 3.83647058 |
97 | ketone body metabolic process (GO:1902224) | 3.80157930 |
98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.79243265 |
99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.79243265 |
100 | protein activation cascade (GO:0072376) | 3.79209669 |
101 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.78911487 |
102 | phospholipid homeostasis (GO:0055091) | 3.78812313 |
103 | negative regulation of lipase activity (GO:0060192) | 3.78350647 |
104 | opsonization (GO:0008228) | 3.77696376 |
105 | serine family amino acid biosynthetic process (GO:0009070) | 3.77634783 |
106 | complement activation, classical pathway (GO:0006958) | 3.76403810 |
107 | heme transport (GO:0015886) | 3.76102484 |
108 | intestinal cholesterol absorption (GO:0030299) | 3.75370405 |
109 | drug catabolic process (GO:0042737) | 3.75313141 |
110 | carboxylic acid catabolic process (GO:0046395) | 3.74786039 |
111 | organic acid catabolic process (GO:0016054) | 3.74786039 |
112 | NAD biosynthetic process (GO:0009435) | 3.72608996 |
113 | complement activation (GO:0006956) | 3.72540340 |
114 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.72288501 |
115 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.72288501 |
116 | uronic acid metabolic process (GO:0006063) | 3.71618070 |
117 | glucuronate metabolic process (GO:0019585) | 3.71618070 |
118 | short-chain fatty acid metabolic process (GO:0046459) | 3.70748626 |
119 | cholesterol homeostasis (GO:0042632) | 3.70474010 |
120 | positive regulation of lipid catabolic process (GO:0050996) | 3.68707419 |
121 | regulation of lipoprotein particle clearance (GO:0010984) | 3.67165438 |
122 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.66061305 |
123 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.66061305 |
124 | cytolysis (GO:0019835) | 3.65830694 |
125 | plasma lipoprotein particle organization (GO:0071827) | 3.65395176 |
126 | sterol homeostasis (GO:0055092) | 3.63695918 |
127 | flavonoid metabolic process (GO:0009812) | 3.63141731 |
128 | acetyl-CoA metabolic process (GO:0006084) | 3.62946741 |
129 | protein-lipid complex assembly (GO:0065005) | 3.62943663 |
130 | regulation of bile acid biosynthetic process (GO:0070857) | 3.62593846 |
131 | regulation of apoptotic cell clearance (GO:2000425) | 3.57461539 |
132 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.52784644 |
133 | acute inflammatory response (GO:0002526) | 3.51593278 |
134 | response to mercury ion (GO:0046689) | 3.46854987 |
135 | steroid catabolic process (GO:0006706) | 3.44866412 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.30928527 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.30367518 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.11283088 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41379650 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.25377370 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.13144601 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.60198455 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.13634303 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01337249 |
10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.44009878 |
11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21348407 |
12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.12152730 |
13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8721753 |
14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96404993 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92897407 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.69019804 |
17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56470641 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51457218 |
19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40767714 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32621507 |
21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23328407 |
22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21594225 |
23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20426295 |
24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.19188832 |
25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17327336 |
26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15604135 |
27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14737407 |
28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06543641 |
29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02711421 |
30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91395631 |
31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90676552 |
32 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87531624 |
33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87020650 |
34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81429676 |
35 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81425267 |
36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78840740 |
37 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78274093 |
38 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.77867912 |
39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77518264 |
40 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77131136 |
41 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76288046 |
42 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.75575690 |
43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75479579 |
44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.75366630 |
45 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.74428591 |
46 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.73914880 |
47 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73426849 |
48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72415113 |
49 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72225774 |
50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.71812346 |
51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.71171923 |
52 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.71171923 |
53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70739226 |
54 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.70675777 |
55 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69616656 |
56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69608091 |
57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69578595 |
58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.69368118 |
59 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68515507 |
60 | NFYA_21822215_ChIP-Seq_K562_Human | 0.67106588 |
61 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.66091576 |
62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66080459 |
63 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.66036594 |
64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65406827 |
65 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64439146 |
66 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.63625516 |
67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.63557656 |
68 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.63152198 |
69 | TP53_16413492_ChIP-PET_HCT116_Human | 0.62732097 |
70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.62642162 |
71 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.62595032 |
72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62534708 |
73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62523503 |
74 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62372343 |
75 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60869508 |
76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.60669973 |
77 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.60358412 |
78 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59443688 |
79 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.58648553 |
80 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.58543941 |
81 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58100004 |
82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58057029 |
83 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.58037441 |
84 | GATA3_26560356_Chip-Seq_TH1_Human | 0.57502404 |
85 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.57071793 |
86 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.56902003 |
87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.56711479 |
88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.56711479 |
89 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.56704431 |
90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.56433672 |
91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.56341026 |
92 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.56300783 |
93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55940008 |
94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.55510792 |
95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.55314895 |
96 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.54591469 |
97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.54050300 |
98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.53541199 |
99 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.53456305 |
100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.53255170 |
101 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53171478 |
102 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.51152854 |
103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50723831 |
104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49472579 |
105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.49084270 |
106 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.49078709 |
107 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48848160 |
108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48727126 |
109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.48003941 |
110 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47899934 |
111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.47715207 |
112 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47480449 |
113 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47045383 |
114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46794659 |
115 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.45770039 |
116 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45726893 |
117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44636808 |
118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.44525292 |
119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.44368375 |
120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44308096 |
121 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.44208230 |
122 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43710936 |
123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.43393278 |
124 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.42713440 |
125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.42694114 |
126 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.42238329 |
127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.42230568 |
128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.41592249 |
129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.41152746 |
130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.40917227 |
131 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.40657960 |
132 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40596207 |
133 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.40505190 |
134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.39160372 |
135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38881335 |
136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38814387 |
137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.38226798 |
138 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.36507299 |
139 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.36226983 |
140 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.35709772 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0002139_abnormal_hepatobiliary_system | 7.87854047 |
2 | MP0005360_urolithiasis | 7.40112803 |
3 | * MP0005085_abnormal_gallbladder_physiolo | 6.48521385 |
4 | MP0005365_abnormal_bile_salt | 6.37578566 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.12441317 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.33990176 |
7 | * MP0003252_abnormal_bile_duct | 3.74530852 |
8 | MP0010329_abnormal_lipoprotein_level | 3.62772583 |
9 | MP0009840_abnormal_foam_cell | 3.29832959 |
10 | MP0005083_abnormal_biliary_tract | 3.21590691 |
11 | MP0003195_calcinosis | 2.89023199 |
12 | MP0005332_abnormal_amino_acid | 2.68834142 |
13 | * MP0001666_abnormal_nutrient_absorption | 2.40852199 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.37078816 |
15 | * MP0000609_abnormal_liver_physiology | 2.23867355 |
16 | * MP0002118_abnormal_lipid_homeostasis | 2.12576880 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.08535259 |
18 | MP0003656_abnormal_erythrocyte_physiolo | 2.07261507 |
19 | * MP0005319_abnormal_enzyme/_coenzyme | 1.85803107 |
20 | MP0001764_abnormal_homeostasis | 1.79387529 |
21 | MP0009697_abnormal_copulation | 1.77203657 |
22 | * MP0003868_abnormal_feces_composition | 1.68062736 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63007968 |
24 | MP0005451_abnormal_body_composition | 1.62684193 |
25 | MP0003186_abnormal_redox_activity | 1.43173536 |
26 | MP0003011_delayed_dark_adaptation | 1.38084173 |
27 | MP0009764_decreased_sensitivity_to | 1.23717434 |
28 | MP0009643_abnormal_urine_homeostasis | 1.21830540 |
29 | * MP0000598_abnormal_liver_morphology | 1.20612794 |
30 | MP0005647_abnormal_sex_gland | 1.17630480 |
31 | MP0009763_increased_sensitivity_to | 1.10406156 |
32 | MP0006036_abnormal_mitochondrial_physio | 1.07045910 |
33 | MP0001915_intracranial_hemorrhage | 1.06623742 |
34 | MP0005636_abnormal_mineral_homeostasis | 1.04589821 |
35 | * MP0008469_abnormal_protein_level | 0.98593169 |
36 | MP0003879_abnormal_hair_cell | 0.97514322 |
37 | MP0005670_abnormal_white_adipose | 0.95735895 |
38 | MP0004130_abnormal_muscle_cell | 0.94531493 |
39 | MP0000604_amyloidosis | 0.91490882 |
40 | * MP0009642_abnormal_blood_homeostasis | 0.90689796 |
41 | MP0002254_reproductive_system_inflammat | 0.89931264 |
42 | MP0004147_increased_porphyrin_level | 0.88953644 |
43 | MP0009765_abnormal_xenobiotic_induced | 0.84772344 |
44 | MP0002078_abnormal_glucose_homeostasis | 0.84197433 |
45 | MP0010368_abnormal_lymphatic_system | 0.83108733 |
46 | MP0005187_abnormal_penis_morphology | 0.83090848 |
47 | MP0005408_hypopigmentation | 0.82929813 |
48 | MP0005376_homeostasis/metabolism_phenot | 0.82661293 |
49 | * MP0002138_abnormal_hepatobiliary_system | 0.80694445 |
50 | MP0005334_abnormal_fat_pad | 0.80220033 |
51 | MP0002971_abnormal_brown_adipose | 0.77437777 |
52 | MP0002876_abnormal_thyroid_physiology | 0.77068592 |
53 | MP0006035_abnormal_mitochondrial_morpho | 0.75906958 |
54 | MP0003705_abnormal_hypodermis_morpholog | 0.74021850 |
55 | MP0005084_abnormal_gallbladder_morpholo | 0.73210374 |
56 | MP0005464_abnormal_platelet_physiology | 0.72667178 |
57 | MP0005220_abnormal_exocrine_pancreas | 0.72377842 |
58 | MP0005266_abnormal_metabolism | 0.71286219 |
59 | MP0005535_abnormal_body_temperature | 0.70066014 |
60 | MP0003183_abnormal_peptide_metabolism | 0.68374845 |
61 | MP0003690_abnormal_glial_cell | 0.63594303 |
62 | MP0001661_extended_life_span | 0.62067398 |
63 | MP0002837_dystrophic_cardiac_calcinosis | 0.59822138 |
64 | MP0003724_increased_susceptibility_to | 0.56155042 |
65 | MP0004381_abnormal_hair_follicle | 0.55253629 |
66 | MP0005448_abnormal_energy_balance | 0.53827413 |
67 | MP0001756_abnormal_urination | 0.51395565 |
68 | MP0002822_catalepsy | 0.51350397 |
69 | MP0000639_abnormal_adrenal_gland | 0.50663315 |
70 | MP0005666_abnormal_adipose_tissue | 0.49999062 |
71 | MP0002132_abnormal_respiratory_system | 0.49358896 |
72 | MP0003436_decreased_susceptibility_to | 0.49065599 |
73 | MP0009053_abnormal_anal_canal | 0.48870554 |
74 | MP0002089_abnormal_postnatal_growth/wei | 0.48652858 |
75 | MP0001853_heart_inflammation | 0.48509457 |
76 | MP0005164_abnormal_response_to | 0.46974938 |
77 | MP0005023_abnormal_wound_healing | 0.45704552 |
78 | * MP0003699_abnormal_female_reproductive | 0.45550997 |
79 | MP0008874_decreased_physiological_sensi | 0.45076160 |
80 | MP0008873_increased_physiological_sensi | 0.44555183 |
81 | MP0005167_abnormal_blood-brain_barrier | 0.44423750 |
82 | MP0005395_other_phenotype | 0.44414513 |
83 | MP0003718_maternal_effect | 0.44048301 |
84 | MP0005075_abnormal_melanosome_morpholog | 0.43173357 |
85 | MP0006082_CNS_inflammation | 0.42983956 |
86 | MP0002136_abnormal_kidney_physiology | 0.42601106 |
87 | MP0003953_abnormal_hormone_level | 0.41926481 |
88 | MP0003172_abnormal_lysosome_physiology | 0.41417895 |
89 | MP0004782_abnormal_surfactant_physiolog | 0.40368672 |
90 | MP0003638_abnormal_response/metabolism_ | 0.40256171 |
91 | MP0001324_abnormal_eye_pigmentation | 0.39825741 |
92 | MP0004883_abnormal_blood_vessel | 0.39705667 |
93 | MP0008872_abnormal_physiological_respon | 0.39380862 |
94 | MP0000685_abnormal_immune_system | 0.39140737 |
95 | MP0005166_decreased_susceptibility_to | 0.38768575 |
96 | MP0003959_abnormal_lean_body | 0.38256195 |
97 | MP0003303_peritoneal_inflammation | 0.37777823 |
98 | MP0006292_abnormal_olfactory_placode | 0.37734172 |
99 | MP0002282_abnormal_trachea_morphology | 0.37201035 |
100 | MP0002090_abnormal_vision | 0.36712598 |
101 | MP0009115_abnormal_fat_cell | 0.36126820 |
102 | MP0000230_abnormal_systemic_arterial | 0.35895430 |
103 | MP0002269_muscular_atrophy | 0.35788971 |
104 | MP0003075_altered_response_to | 0.35674179 |
105 | MP0005410_abnormal_fertilization | 0.34920968 |
106 | * MP0001845_abnormal_inflammatory_respons | 0.33623793 |
107 | MP0009672_abnormal_birth_weight | 0.33002626 |
108 | MP0003950_abnormal_plasma_membrane | 0.32473779 |
109 | MP0003329_amyloid_beta_deposits | 0.32165602 |
110 | MP0002970_abnormal_white_adipose | 0.32013374 |
111 | MP0000249_abnormal_blood_vessel | 0.30920360 |
112 | MP0000371_diluted_coat_color | 0.30183500 |
113 | MP0000579_abnormal_nail_morphology | 0.29505731 |
114 | MP0002332_abnormal_exercise_endurance | 0.29238314 |
115 | MP0005058_abnormal_lysosome_morphology | 0.29213080 |
116 | MP0001243_abnormal_dermal_layer | 0.27659317 |
117 | MP0005397_hematopoietic_system_phenotyp | 0.26677747 |
118 | MP0001545_abnormal_hematopoietic_system | 0.26677747 |
119 | MP0003890_abnormal_embryonic-extraembry | 0.25978023 |
120 | MP0002168_other_aberrant_phenotype | 0.25835817 |
121 | MP0003646_muscle_fatigue | 0.25191681 |
122 | MP0001800_abnormal_humoral_immune | 0.24928761 |
123 | MP0002419_abnormal_innate_immunity | 0.24758925 |
124 | MP0000920_abnormal_myelination | 0.23959395 |
125 | MP0005197_abnormal_uvea_morphology | 0.23604458 |
126 | MP0009785_altered_susceptibility_to | 0.23451392 |
127 | MP0003633_abnormal_nervous_system | 0.22861597 |
128 | MP0005025_abnormal_response_to | 0.21891517 |
129 | MP0001881_abnormal_mammary_gland | 0.20697817 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.11652464 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.08220125 |
3 | * Intrahepatic cholestasis (HP:0001406) | 7.03466264 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.61303911 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.34791292 |
6 | Xanthomatosis (HP:0000991) | 6.21450192 |
7 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.20435087 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.50372233 |
9 | Complement deficiency (HP:0004431) | 5.33570429 |
10 | Joint hemorrhage (HP:0005261) | 4.89440780 |
11 | Hypolipoproteinemia (HP:0010981) | 4.85415256 |
12 | Hyperammonemia (HP:0001987) | 4.61566253 |
13 | Epidermoid cyst (HP:0200040) | 4.53140122 |
14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.47864695 |
15 | Abnormality of methionine metabolism (HP:0010901) | 4.39638423 |
16 | Hyperglycinemia (HP:0002154) | 4.38006629 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.36443638 |
18 | Hypoalphalipoproteinemia (HP:0003233) | 4.32922052 |
19 | Ketosis (HP:0001946) | 4.31851855 |
20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22100352 |
21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15677974 |
22 | Fat malabsorption (HP:0002630) | 4.08657544 |
23 | Hypoglycemic coma (HP:0001325) | 3.92918881 |
24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91672960 |
25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.87936975 |
26 | Abnormality of complement system (HP:0005339) | 3.86936386 |
27 | Nephritis (HP:0000123) | 3.81863805 |
28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.80186711 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.75627815 |
30 | Abnormality of glycine metabolism (HP:0010895) | 3.75627815 |
31 | Hyperglycinuria (HP:0003108) | 3.75274732 |
32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.74464114 |
33 | Hypercholesterolemia (HP:0003124) | 3.71504789 |
34 | Osteomalacia (HP:0002749) | 3.69730545 |
35 | Hyperbilirubinemia (HP:0002904) | 3.68550486 |
36 | Hypochromic microcytic anemia (HP:0004840) | 3.41454745 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.40513831 |
38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.38732063 |
39 | Acanthocytosis (HP:0001927) | 3.19770737 |
40 | Hepatocellular carcinoma (HP:0001402) | 3.16775451 |
41 | Abnormality of serum amino acid levels (HP:0003112) | 3.15370608 |
42 | Ketoacidosis (HP:0001993) | 3.09292793 |
43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08173001 |
44 | Steatorrhea (HP:0002570) | 3.04196867 |
45 | Spontaneous abortion (HP:0005268) | 2.92260698 |
46 | Metabolic acidosis (HP:0001942) | 2.92139943 |
47 | Reduced antithrombin III activity (HP:0001976) | 2.90024933 |
48 | Delayed CNS myelination (HP:0002188) | 2.89167748 |
49 | Myocardial infarction (HP:0001658) | 2.86438200 |
50 | Systemic lupus erythematosus (HP:0002725) | 2.80748182 |
51 | Poikilocytosis (HP:0004447) | 2.80484223 |
52 | Fair hair (HP:0002286) | 2.76907530 |
53 | Purpura (HP:0000979) | 2.70418263 |
54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69871415 |
55 | Dicarboxylic aciduria (HP:0003215) | 2.69871415 |
56 | Skin nodule (HP:0200036) | 2.68744205 |
57 | Abnormality of purine metabolism (HP:0004352) | 2.66423022 |
58 | Lethargy (HP:0001254) | 2.65191069 |
59 | Pulmonary embolism (HP:0002204) | 2.64012195 |
60 | Cerebral edema (HP:0002181) | 2.55148894 |
61 | Vascular calcification (HP:0004934) | 2.54946193 |
62 | Hypoglycemic seizures (HP:0002173) | 2.52464567 |
63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44052532 |
64 | * Abnormal gallbladder morphology (HP:0012437) | 2.43910213 |
65 | Glomerulonephritis (HP:0000099) | 2.43327835 |
66 | * Cholelithiasis (HP:0001081) | 2.39134333 |
67 | Gingival bleeding (HP:0000225) | 2.37978980 |
68 | Mitral stenosis (HP:0001718) | 2.31324583 |
69 | Gout (HP:0001997) | 2.31151226 |
70 | Neonatal onset (HP:0003623) | 2.24266463 |
71 | Renal cortical cysts (HP:0000803) | 2.24024904 |
72 | Cardiovascular calcification (HP:0011915) | 2.21884200 |
73 | Enlarged kidneys (HP:0000105) | 2.21142956 |
74 | Spastic diplegia (HP:0001264) | 2.20554201 |
75 | Amyloidosis (HP:0011034) | 2.19697834 |
76 | Brushfield spots (HP:0001088) | 2.18460185 |
77 | Menorrhagia (HP:0000132) | 2.16494150 |
78 | Abnormality of iron homeostasis (HP:0011031) | 2.16396060 |
79 | Irritability (HP:0000737) | 2.13812970 |
80 | Reticulocytosis (HP:0001923) | 2.13359842 |
81 | Vomiting (HP:0002013) | 2.11847123 |
82 | Sensorimotor neuropathy (HP:0007141) | 2.10997934 |
83 | Generalized aminoaciduria (HP:0002909) | 2.10529242 |
84 | Malnutrition (HP:0004395) | 2.10334239 |
85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09703248 |
86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09165454 |
87 | Thrombophlebitis (HP:0004418) | 2.08801947 |
88 | Late onset (HP:0003584) | 2.08090436 |
89 | Esophageal varix (HP:0002040) | 2.06256151 |
90 | Arthropathy (HP:0003040) | 2.03935409 |
91 | Opisthotonus (HP:0002179) | 2.02385083 |
92 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.95521259 |
93 | * Abnormality of the gallbladder (HP:0005264) | 1.94041162 |
94 | * Pancreatitis (HP:0001733) | 1.92821558 |
95 | Gangrene (HP:0100758) | 1.89350981 |
96 | Hemorrhage of the eye (HP:0011885) | 1.88992102 |
97 | Abnormality of the Achilles tendon (HP:0005109) | 1.88263353 |
98 | Hyperphosphaturia (HP:0003109) | 1.87659915 |
99 | * Elevated hepatic transaminases (HP:0002910) | 1.87529005 |
100 | Generalized hypopigmentation of hair (HP:0011358) | 1.86167308 |
101 | Rickets (HP:0002748) | 1.85344139 |
102 | Epistaxis (HP:0000421) | 1.84423255 |
103 | Neonatal hypoglycemia (HP:0001998) | 1.83992302 |
104 | Increased serum ferritin (HP:0003281) | 1.82034737 |
105 | Hyperglycemia (HP:0003074) | 1.80597999 |
106 | Proximal tubulopathy (HP:0000114) | 1.78427197 |
107 | Hypertriglyceridemia (HP:0002155) | 1.77043783 |
108 | Hypophosphatemia (HP:0002148) | 1.76673544 |
109 | Abnormality of vitamin metabolism (HP:0100508) | 1.76364150 |
110 | Abnormal tarsal ossification (HP:0008369) | 1.75905893 |
111 | * Elevated alkaline phosphatase (HP:0003155) | 1.75099660 |
112 | Abnormal urine phosphate concentration (HP:0012599) | 1.74072766 |
113 | Nausea (HP:0002018) | 1.72345497 |
114 | Hyperuricemia (HP:0002149) | 1.70987801 |
115 | Increased purine levels (HP:0004368) | 1.70987801 |
116 | Glycosuria (HP:0003076) | 1.69563294 |
117 | Abnormality of urine glucose concentration (HP:0011016) | 1.69563294 |
118 | Hypophosphatemic rickets (HP:0004912) | 1.69345502 |
119 | Joint swelling (HP:0001386) | 1.67662614 |
120 | Lower limb hyperreflexia (HP:0002395) | 1.57420003 |
121 | * Abnormal enzyme/coenzyme activity (HP:0012379) | 1.57181678 |
122 | Increased serum pyruvate (HP:0003542) | 1.57134088 |
123 | Retinal atrophy (HP:0001105) | 1.56968033 |
124 | Bifid scrotum (HP:0000048) | 1.55738778 |
125 | * Abnormality of alkaline phosphatase activity (HP:0004379) | 1.53836285 |
126 | Abnormality of proline metabolism (HP:0010907) | 1.52023108 |
127 | Hydroxyprolinuria (HP:0003080) | 1.52023108 |
128 | Atrioventricular block (HP:0001678) | 1.46339000 |
129 | Blue irides (HP:0000635) | 1.43460705 |
130 | Polycythemia (HP:0001901) | 1.40740436 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.41385895 |
2 | SIK1 | 3.82290739 |
3 | FGFR4 | 3.73612386 |
4 | TAOK3 | 3.58623039 |
5 | INSRR | 3.57841699 |
6 | MAP3K13 | 3.47069136 |
7 | ERN1 | 3.39559111 |
8 | MAP3K9 | 2.58183121 |
9 | ARAF | 2.56585748 |
10 | ERBB4 | 2.55513187 |
11 | PIK3CG | 2.46893939 |
12 | BLK | 2.37086564 |
13 | MAP2K4 | 2.32087362 |
14 | PKN2 | 2.27388351 |
15 | CDK12 | 2.25181957 |
16 | FLT3 | 2.22611343 |
17 | MAPK11 | 2.01838873 |
18 | MST1R | 2.00262851 |
19 | TYK2 | 1.99615990 |
20 | CDK9 | 1.70642765 |
21 | PINK1 | 1.69436426 |
22 | MAP2K3 | 1.66924150 |
23 | NEK9 | 1.62925096 |
24 | STK3 | 1.60580054 |
25 | OBSCN | 1.56023383 |
26 | ICK | 1.49021888 |
27 | MAP3K7 | 1.46963573 |
28 | TBK1 | 1.44936950 |
29 | PTK6 | 1.43321921 |
30 | IRAK3 | 1.39774585 |
31 | MAP3K14 | 1.38079010 |
32 | PRPF4B | 1.37267146 |
33 | JAK2 | 1.35670468 |
34 | PRKAA2 | 1.29014214 |
35 | ABL2 | 1.25374583 |
36 | TNK2 | 1.25363248 |
37 | DAPK2 | 1.24241030 |
38 | PDK1 | 1.18242198 |
39 | LATS1 | 1.17371578 |
40 | JAK1 | 1.16085895 |
41 | MOS | 1.14468314 |
42 | MARK3 | 1.13616493 |
43 | TRIB3 | 1.11625296 |
44 | KDR | 1.09339952 |
45 | PRKG1 | 1.06246687 |
46 | MAPK4 | 1.05993342 |
47 | STK16 | 1.05607832 |
48 | KSR2 | 1.05588979 |
49 | TIE1 | 1.03920181 |
50 | MAPK12 | 1.03509428 |
51 | NEK6 | 1.01982014 |
52 | NME2 | 1.01046466 |
53 | EIF2AK3 | 0.98068978 |
54 | MAP3K10 | 0.95431145 |
55 | MELK | 0.95010091 |
56 | FRK | 0.92358950 |
57 | MAP3K3 | 0.91064645 |
58 | TGFBR2 | 0.90941941 |
59 | STK24 | 0.89970546 |
60 | PIK3CA | 0.89731191 |
61 | TAOK2 | 0.88879917 |
62 | KIT | 0.88502827 |
63 | NTRK3 | 0.88438649 |
64 | ERBB2 | 0.86955972 |
65 | PRKAA1 | 0.86075036 |
66 | NLK | 0.84812950 |
67 | MAP2K6 | 0.83065750 |
68 | MAPK15 | 0.80543082 |
69 | CDK6 | 0.80125962 |
70 | MAP4K1 | 0.77891280 |
71 | BRAF | 0.77319466 |
72 | GRK6 | 0.76853047 |
73 | SYK | 0.74811264 |
74 | PRKACG | 0.74714885 |
75 | STK38L | 0.72997837 |
76 | CDK4 | 0.72825127 |
77 | CSNK1D | 0.71625446 |
78 | MAP3K11 | 0.71501196 |
79 | IKBKE | 0.69888767 |
80 | PRKACA | 0.69613745 |
81 | EPHA3 | 0.69161500 |
82 | GRK1 | 0.68505005 |
83 | SGK3 | 0.67719032 |
84 | MAP3K6 | 0.67266098 |
85 | CDC42BPA | 0.66233795 |
86 | PRKCZ | 0.64294129 |
87 | CAMK1D | 0.63694196 |
88 | ACVR1B | 0.62565759 |
89 | SGK1 | 0.62492355 |
90 | MAPK7 | 0.61654523 |
91 | CSF1R | 0.61399186 |
92 | CAMK2G | 0.59532321 |
93 | MAP3K5 | 0.59334505 |
94 | CSK | 0.58167549 |
95 | SGK2 | 0.56321324 |
96 | FGR | 0.54964343 |
97 | PRKACB | 0.53759569 |
98 | TRPM7 | 0.53324783 |
99 | CHUK | 0.53157298 |
100 | FGFR2 | 0.52951719 |
101 | MAPKAPK3 | 0.52767452 |
102 | PRKCQ | 0.52224264 |
103 | ZAP70 | 0.51431775 |
104 | RAF1 | 0.50551642 |
105 | GSK3A | 0.49243252 |
106 | RPS6KB1 | 0.46361975 |
107 | SGK223 | 0.46018212 |
108 | SGK494 | 0.46018212 |
109 | MTOR | 0.45783559 |
110 | JAK3 | 0.45680203 |
111 | RPS6KA3 | 0.43782501 |
112 | ZAK | 0.42912756 |
113 | CDK7 | 0.41511329 |
114 | MUSK | 0.41477186 |
115 | PKN1 | 0.41240314 |
116 | PIM1 | 0.41169644 |
117 | RIPK1 | 0.37390420 |
118 | EPHB1 | 0.36041484 |
119 | DYRK1B | 0.35431014 |
120 | NUAK1 | 0.35231557 |
121 | IGF1R | 0.34982996 |
122 | MET | 0.34332067 |
123 | STK4 | 0.32845185 |
124 | LYN | 0.32472027 |
125 | PHKG2 | 0.31777519 |
126 | PHKG1 | 0.31777519 |
127 | IRAK1 | 0.31234875 |
128 | PRKCB | 0.31198466 |
129 | CSNK1G1 | 0.29545140 |
130 | PBK | 0.28041333 |
131 | EIF2AK2 | 0.27927126 |
132 | FGFR3 | 0.27891380 |
133 | PDPK1 | 0.27690296 |
134 | MATK | 0.27420334 |
135 | MAP2K1 | 0.27150723 |
136 | IKBKB | 0.26566960 |
137 | CAMK4 | 0.26448404 |
138 | PRKCG | 0.24604948 |
139 | MAPK3 | 0.24529960 |
140 | MAP3K1 | 0.23655944 |
141 | RET | 0.23651109 |
142 | BTK | 0.23257392 |
143 | EGFR | 0.23212708 |
144 | PRKCA | 0.22171333 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56163804 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45849599 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.36852419 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28529420 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98669591 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78767067 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71312913 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68529750 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60542211 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55730144 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47644961 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40376787 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25323358 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.14710063 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08212094 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07545928 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01844231 |
18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92949021 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89549875 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88981117 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87323733 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86015812 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85172047 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81039881 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80010408 |
26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.78243793 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76439111 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73833789 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73532575 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70404057 |
31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67563421 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64144128 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53700170 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49186225 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47758397 |
36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41378388 |
37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38825114 |
38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37133905 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36439046 |
40 | * Bile secretion_Homo sapiens_hsa04976 | 1.36434304 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32854280 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26069575 |
43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25708733 |
44 | * ABC transporters_Homo sapiens_hsa02010 | 1.22914408 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19574667 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13452953 |
47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12234807 |
48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10387399 |
49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06875799 |
50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04734330 |
51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01733160 |
52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98479768 |
53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97172802 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96322719 |
55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95950922 |
56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90577306 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89881132 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.88584816 |
59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76684144 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70683523 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69766806 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63496345 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60703418 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58489849 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54471767 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51710169 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49132296 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40221614 |
69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31147173 |
70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29864850 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29590071 |
72 | Prion diseases_Homo sapiens_hsa05020 | 0.28951954 |
73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28262765 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.27523966 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24222437 |
76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20150666 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18362304 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13886472 |
79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.06504337 |
80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05209319 |
81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04244800 |
82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03569304 |
83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.02612211 |
84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2440994 |
85 | Allograft rejection_Homo sapiens_hsa05330 | -0.2419094 |
86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.2345460 |
87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2290398 |
88 | Pertussis_Homo sapiens_hsa05133 | -0.2245142 |
89 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2239020 |
90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2173911 |
91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | -0.2163754 |
92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2160287 |
93 | Asthma_Homo sapiens_hsa05310 | -0.2149808 |
94 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2118437 |
95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2098750 |
96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2038542 |
97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1850354 |
98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1650975 |
99 | Lysosome_Homo sapiens_hsa04142 | -0.1587105 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1523012 |
101 | Mineral absorption_Homo sapiens_hsa04978 | -0.1425068 |
102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1421638 |
103 | Hepatitis C_Homo sapiens_hsa05160 | -0.1386614 |
104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1251635 |
105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1185707 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1145225 |
107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1066061 |
108 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0822999 |
109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0663314 |
110 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0496022 |
111 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0397705 |
112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0253177 |
113 | Amoebiasis_Homo sapiens_hsa05146 | -0.0041782 |